1. 145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment. (10th December 2020) Authors: Wong, Karrie; Sexton, Steven; Donahue, Kelly; Antony, Lincy Prem; Wasko, Kevin; Nasser, Jared; Leary, Glenn; Pfautz, Amanda; Porth, Owen; Pierce, William; Sousa, Patricia; Scott, Sean; Wilson, Aaron; Chang, Kai-Hsin; Zuris, John; Wilson, Christopher; Morgan, Richard; Borges, Christopher Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗